Project Grant HT94252510394
Award Date 8/15/25
Completion Date 8/14/29
Dollars Obligated $435K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,671,990.00 to the University of Pittsburgh for a collaborative, multiomic approach to molecularly characterize and stratify pediatric scleroderma patients. The 4-year project aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research in this area. The award began on Aug 15, 2025 and is...
- The University of Pittsburgh was awarded a $494,458 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to regulate profibrotic SPP1-expressing macrophages by TFEB in SSc. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative medical...
- The University of Pittsburgh received a three-year Project Grant award of $692,838 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into scleroderma-associated interstitial lung disease, the most common cause of death for patients with systemic sclerosis. Through June 2025, the University of Pittsburgh will investigate medical solutions for this complication as part of the program's mission...
- This $300,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Pittsburgh to uncover the nuclear antigens recognized by autoreactive T cells in systemic lupus erythematosus (SLE). The research aims to transform healthcare for military service members and the broader public by advancing scientific understanding of this autoimmune disease. The project will be conducted over a period...
- The University of Pittsburgh is the recipient of a $1,272,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, titled "The Pittsburgh ASPIRES Bridge Builder Project: Connecting Advocates, Scientists, Patients, and Institutions for Research Expansion in Sarcoma," is intended to support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
- The University of Pittsburgh was awarded a $2,077,852 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 2022 through August 2025 to study the pros and cons of NRF2 in focal segmental glomerulosclerosis (FSGS) pathogenesis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- This federal Project Grant award of $673,197.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Pittsburgh to harmonize and analyze multi-omic data on severe traumatic brain injury. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The project will be...
- The University of Pittsburgh has been awarded a $726,989 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA." The three-year award, commencing on September 15, 2025, aims to advance biomedical research to transform healthcare for military service members, veterans, and the broader public. The research project will investigate medical...
- This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...